Skip to content
The Policy VaultThe Policy Vault

Gleevec (imatinib tablets) — Medica

Chronic myeloid leukemia (CML)

Initial criteria

  • Patient has Philadelphia chromosome-positive chronic myeloid leukemia OR patient has BCR::ABL1-mutation positive chronic myeloid leukemia

Approval duration

1 year